1. Liposomal N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor F96 as a new therapy for colitis. Issue 56 (15th September 2020) Authors: Xiu, Yangyan; Wang, Kaizhen; Chen, Jingfang; Zhuo, Zhiqiang; Xiu, Yanghui Journal: RSC advances Issue: Volume 10:Issue 56(2020) Page Start: 34197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗